AGORANOV

Summary

AGORANOV is the famous Corporate Investor, which was founded in 2000. The fund was located in Europe if to be more exact in France. The main office of represented Corporate Investor is situated in the Paris.

Among the various public portfolio startups of the fund, we may underline Criteo, Doctolib, Ynsect The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular fund investment industries, there are Health Care, Medical Device. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.

Besides them, we counted 1 critical employee of this fund in our database.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the AGORANOV, startups are often financed by Wilco, NUMA, Bpifrance. The meaningful sponsors for the fund in investment in the same round are The Family, Sowefund, Kurma Partners. In the next rounds fund is usually obtained by XAnge, CapDecisif, Kima Ventures.

The top amount of exits for fund were in 2018. Speaking about the real fund results, this Corporate Investor is 19 percentage points less often commits exit comparing to other organizations. This AGORANOV works on 19 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in 13-24 deals per year.